444 related articles for article (PubMed ID: 10555200)
1. Acyclovir treatment prevents varicella-zoster virus replication in PBMC during viremia.
Wolff MH; Schünemann S
New Microbiol; 1999 Oct; 22(4):309-14. PubMed ID: 10555200
[TBL] [Abstract][Full Text] [Related]
2. No acute varicella-zoster virus replication in peripheral blood mononuclear cells during postherpetic neuralgia.
Schünemann S; Mainka C; Wolff MH
Acta Virol; 1999 Dec; 43(6):337-40. PubMed ID: 10825921
[TBL] [Abstract][Full Text] [Related]
3. Effect of acyclovir and prednisolone on the serological response in herpes zoster.
Bates CJ; Kudesia G; McKendrick MW
J Med Virol; 1996 Nov; 50(3):244-8. PubMed ID: 8923289
[TBL] [Abstract][Full Text] [Related]
4. Viremia in acute herpes zoster.
Satyaprakash AK; Tremaine AM; Stelter AA; Creed R; Ravanfar P; Mendoza N; Mehta SK; Rady PL; Pierson DL; Tyring SK
J Infect Dis; 2009 Jul; 200(1):26-32. PubMed ID: 19469706
[TBL] [Abstract][Full Text] [Related]
5. Molecular and therapeutic aspects of varicella-zoster virus infection.
Quinlivan M; Breuer J
Expert Rev Mol Med; 2005 Aug; 7(15):1-24. PubMed ID: 16098235
[TBL] [Abstract][Full Text] [Related]
6. Varicella zoster virus: natural history and current therapies of varicella and herpes zoster.
Breuer J; Whitley R
Herpes; 2007 Sep; 14 Suppl 2():25-9. PubMed ID: 17939892
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathologic understanding and control of varicella-zoster virus infection.
Asano Y
Vaccine; 2008 Nov; 26(50):6487-90. PubMed ID: 18694794
[TBL] [Abstract][Full Text] [Related]
8. Clinical features and risk factors for developing varicella zoster virus dissemination following hematopoietic stem cell transplantation.
Umezawa Y; Kakihana K; Oshikawa G; Kobayashi T; Doki N; Sakamaki H; Ohashi K
Transpl Infect Dis; 2014 Apr; 16(2):195-202. PubMed ID: 24438510
[TBL] [Abstract][Full Text] [Related]
9. Clinical relevance of quantitative varicella-zoster virus (VZV) DNA detection in plasma after stem cell transplantation.
Kalpoe JS; Kroes AC; Verkerk S; Claas EC; Barge RM; Beersma MF
Bone Marrow Transplant; 2006 Jul; 38(1):41-6. PubMed ID: 16715108
[TBL] [Abstract][Full Text] [Related]
10. Advances in the treatment of varicella-zoster virus infections.
Andrei G; Snoeck R
Adv Pharmacol; 2013; 67():107-68. PubMed ID: 23886000
[TBL] [Abstract][Full Text] [Related]
11. Varicella-zoster virus infections in the immunocompromised host. Natural history and treatment.
Balfour HH
Scand J Infect Dis Suppl; 1991; 80():69-74. PubMed ID: 1666447
[TBL] [Abstract][Full Text] [Related]
12. Incidence, risk factors and outcome of varicella-zoster virus infection in children after haematopoietic stem cell transplantation.
Leung TF; Chik KW; Li CK; Lai H; Shing MM; Chan PK; Lee V; Yuen PM
Bone Marrow Transplant; 2000 Jan; 25(2):167-72. PubMed ID: 10673675
[TBL] [Abstract][Full Text] [Related]
13. [Contribution of the laboratory in case of resistance to acyclovir of herpes simplex and varicella zoster virus].
Morfin F; Frobert E; Thouvenot D
Ann Biol Clin (Paris); 2003; 61(1):33-40. PubMed ID: 12604384
[TBL] [Abstract][Full Text] [Related]
14. Acyclovir-resistant varicella-zoster virus: phenotypic and genetic characterization.
Fillet AM; Dumont B; Caumes E; Visse B; Agut H; Bricaire F; Huraux JM
J Med Virol; 1998 Jul; 55(3):250-4. PubMed ID: 9624615
[TBL] [Abstract][Full Text] [Related]
15. [Acyclovir and specific anti-varicella-herpes zoster immunoglobulins in the treatment of varicella-zoster virus infection in 113 adults].
Senneville E; Chidiac C; Brouillard M; Beuscart C; Leroy O; Sivery B; Beaucaire G; Mouton Y
Pathol Biol (Paris); 1990 Jun; 38(5 ( Pt 2)):568-71. PubMed ID: 2166935
[TBL] [Abstract][Full Text] [Related]
16. Retrospective analysis of varicella zoster virus (VZV) copy DNA numbers in plasma of immunocompetent patients with herpes zoster, of immunocompromised patients with disseminated VZV disease, and of asymptomatic solid organ transplant recipients.
Kronenberg A; Bossart W; Wuthrich RP; Cao C; Lautenschlager S; Wiegand ND; Mullhaupt B; Noll G; Mueller NJ; Speck RF
Transpl Infect Dis; 2005; 7(3-4):116-21. PubMed ID: 16390399
[TBL] [Abstract][Full Text] [Related]
17. Persistence and antiviral resistance of varicella zoster virus in hematological patients.
van der Beek MT; Vermont CL; Bredius RG; Marijt EW; van der Blij-de Brouwer CS; Kroes AC; Claas EC; Vossen AC
Clin Infect Dis; 2013 Feb; 56(3):335-43. PubMed ID: 23074321
[TBL] [Abstract][Full Text] [Related]
18. Brief presence of varicella-zoster vral DNA in mononuclear cells during relapses of multiple sclerosis.
Ordoñez G; Pineda B; Garcia-Navarrete R; Sotelo J
Arch Neurol; 2004 Apr; 61(4):529-32. PubMed ID: 15096401
[TBL] [Abstract][Full Text] [Related]
19. Characterization of acyclovir susceptibility and genetic stability of varicella-zoster viruses isolated during acyclovir therapy.
Ida M; Kageyama S; Sato H; Kamiyama T; Toyomoto T; Ozaki T; Kajita Y; Morohashi M; Shiraki K
J Dermatol Sci; 2000 May; 23(1):63-72. PubMed ID: 10699766
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory activity of oxyresveratrol on wild-type and drug-resistant varicella-zoster virus replication in vitro.
Sasivimolphan P; Lipipun V; Likhitwitayawuid K; Takemoto M; Pramyothin P; Hattori M; Shiraki K
Antiviral Res; 2009 Oct; 84(1):95-7. PubMed ID: 19635502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
